fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Alkem Laboratories Ltd

Alkem Laboratories Ltd

Updated on November 12, 2019

Stock/Share Code - ALKEM

Alkem Laboratories is a leading Indian Pharmaceutical company with Global operations, engaged in the development, Manufacture and sale of Pharmaceutical and Nutraceutical Products.(Source : 201903 Annual Report Page No: 04)

Below is the details of ALKEM Alkem Laboratories Ltd

Market Cap₹21,733 Cr.
Current Price ₹2,058.25 as on 15 Nov 19
52 Week High / Low Price₹2,268 / ₹1,660
Face Value₹2
Stock P/E24.67
Book Value₹457.09
Dividend Yield0.88 %
ROCE17.09 %
ROE15.48 %
Sales Growth (3yrs)13.47 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is virtually debt free. Company has been maintaining a healthy dividend payout of 21.98%
Cons: Tax rate seems low

Alkem Laboratories Ltd Price Chart

Alkem Laboratories Ltd Price Chart

Alkem Laboratories Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹151.85 26.68 ₹108,066.05 Cr. 0.61 ₹1,387.48 Cr. 31.23 15.92 8374.36 11.19
2. Dr Reddy's Labs ₹2,730.8 19.76 ₹42,483.61 Cr. 0.78 ₹676.5 Cr. 42.09 3.26 3858.20 12.42
3. Piramal Enterp. ₹1,766.95 20.20 ₹40,383.41 Cr. 1.28 ₹450.89 Cr. 125.88 20.80 3506.25 9.42
4. Cipla ₹463.25 24.49 ₹38,074.18 Cr. 0.63 ₹478.19 Cr. 5.97 1.27 3989.02 10.94
5. Aurobindo Pharma ₹410.25 13.43 ₹35,197.33 Cr. 0.42 ₹635.83 Cr. 41.59 28.10 5444.60 18.45
6. Torrent Pharma. ₹14.25 36.90 ₹28,896.01 Cr. 1.00 ₹216 Cr. 32.52 8.01 2022.00 12.66
7. Biocon ₹257.25 34.11 ₹28,272 Cr. 0.21 ₹206.3 Cr. 72.35 30.44 1465.90 13.39
8. Alkem Lab 24.67 ₹21,733.33 Cr. 0.88 ₹210.62 Cr. 62.65 18.00 1498.51 17.09

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Alkem Laboratories Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019
Sales1,3271,1611,0061,1441,5621,4231,1551,2701,4401,5361,4681,499
YOY Sales Growth %18.31%14.75%18.07%-2.59%17.67%22.59%14.86%10.96%-7.78%7.96%27.06%18%
Expenses1,0279408969931,1261,1091,0801,0901,1371,2121,2301,233
Material Cost %39.38%36.86%38.14%43.83%37.5%35.77%41.47%38.94%38.47%40.2%41.28%38.13%
Employee Cost %14.17%17.12%15.81%17.19%14.22%15.69%19.01%19.12%15.86%15.89%16.69%18.92%
Operating Profit30122110915143631475180304324238265
OPM %23%19%11%13%28%22%7%14%21%21%16%18%
Other Income31233024272225192361913
Interest77581176109719
Depreciation192020232628303233354140
Profit before tax30521711514442630164158285287215229
Tax %3%2%-7%22%22%29%6%18%16%16%11%8%
Net Profit29521412311233121360129238241191211
EPS in Rs24.6817.8710.279.3827.6617.815.0210.8319.9320.1815.9617.62
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales9741,1581,3441,6301,9242,2912,6603,0723,9114,5485,2815,7145,943
Sales Growth %9.05%18.97%16.03%21.3%18.04%19.07%16.11%15.49%27.29%16.3%16.11%8.2%%
Expenses8481,0131,1361,3191,5181,8622,2622,7273,1803,6684,3084,6674,812
Material Cost %49.4%49.22%44.88%43.7%40.24%39.39%43.02%45.53%39.56%39.47%39.3%39.76%%
Manufacturing Cost %6.25%6.25%3.47%5.41%6.09%6.05%5.46%4.09%6.96%6.44%6.62%6.47%%
Employee Cost %10.99%11.04%13.43%15.44%14.34%16.08%17.05%18.25%16.02%15.88%16.32%16.8%%
Other Cost %20.69%21.1%22.73%16.62%18.48%20.18%19.96%21.34%19.21%18.87%19.34%18.63%%
Operating Profit1261462083114064293983467318809731,0481,131
OPM %13%13%15%19%21%19%15%11%19%19%18%18%19%
Other Income4859781111351681651822401151016661
Interest15152037537984735924322827
Depreciation20212127283643607476108141150
Profit before tax1391692453574604824363958398949349441,015
Tax %-5%6%3%10%6%3%-1%7%17%1%23%15%
Net Profit145158238322432467440368700883716800881
EPS in Rs58.5773.8759.8866.9073.69
Dividend Payout %8%9%6%6%6%5%5%13%22%20%22%24%

Compounded Sales Growth

  • 10 Years:: 17.30%
  • 5 Years:: 16.52%
  • 3 Years:: 13.47%
  • TTM:: 9.85%

Compounded Profit Growth

  • 10 Years:: 18.69%
  • 5 Years:: 12.63%
  • 3 Years:: 4.15%
  • TTM:: 20.15%

Return on Equity

  • 10 Years:: 18.50%
  • 5 Years:: 17.18%
  • 3 Years:: 17.39%
  • Last Year:: 15.48%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Share Capital121212121212122424242424
Equity Capital11.9611.9611.9611.9611.9611.9611.9623.9123.9123.9123.9123.91
Reserves8349731,1931,4481,8522,2912,7033,0773,5764,3694,8615,441
Borrowings288403707288241,2299471,103380368548503
Other Liabilities1432072974084994995746869891,3001,5631,523
Trade Payables79.45112.32174.41163.24259.02254.34276.05346.53466.5685.24818.56754.09
Total Liabilities1,2771,5951,5722,5963,1874,0324,2364,8904,9696,0606,9967,491
Fixed Assets3723903924846658329098708751,1261,4711,606
Gross Block434.25472.97498.07484.31664.92832.06909.391156.17944.721262.91713.691973.17
Accumulated Depreciation62.4982.96105.90000285.7170.04137.27242.7366.79
CWIP1368000096147218299382
Investments1932620533725799401,0711,1581,5181,5441,696
Other Assets7001,1731,1512,0582,1502,6202,3862,8532,7903,1993,6823,808
Inventories205.8195.92175.7227.92309.22452.8504.56548.24590.03858.761024.16991.28
Trade receivables98.35106.4116.81162.15251.71291.81290.32375.01480.44633.32875966.64
Cash Equivalents300.01727.88661.56980.17493.25965.18122.76633.32524.03199.06278.3397.94
Loans n Advances95.46142.7197.31100.44152.32237.03186.98190.01767.931038.011273.021341.27
Other Assets etc000587.43943.37673.251281.581106.51427.64469.61231.1110.49
Total Assets1,2771,5951,5722,5963,1874,0324,2364,8904,9696,0606,9967,491

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity188245-8419815297264242630499318743
Profit from operations133.01155.94242.04331.23415.57439.56404.56362.89773.51890.51011.681074.02
Working Capital Changes87.84144.76-326.13-67.05-167.47-235.93-31.76-15.73.38-186.67-512.07-126.67
Taxes paid-32.4-55.220-66.59-96.6-106.7-108.52-105.64-147.08-204.77-181.35-204.5
Cash from Investing Activity-11718542-723-279-349119-260311-362-273-311
Fixed Assets Purchased-73.14-31.09-28.04-117.16-244.49-202.88-96.52-133.03-170.63-460.25-498.71-354.89
Fixed Assets Sold00001.311.333.252.793.348.125.821.58
Investments purchased-339.16-193.790-22.85-270.03-27000-41.8600
Investments sold272.9374.6320.070009.87101.7932.7091.07128.9
Cash from Financing Activity-11-2-2462519274-39526-958-125-60-276
Proceeds from Borrowings3.0615.3613.71662.1793.5421.570201.06-695.6615.03188.250
Repayment of Borrowings00000-16.91-279.1-45.61-26.45-29.650-31.69
Interest Paid00-20.4-37.3900-84.2-72.82-53.35-23.68-32.37-28.26
Dividends Paid-13.99-17.48-14.950-53.2-79.24-31.86-56.68-182.7-86.34-215.86-215.8
Net Cash Flow60428-6699-10821-128-1713-15156

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %14%13%19%22%21%18%15%11%22%21%19%17%
Debtor Days373432364846404545516062
Inventory Turnover5.095.777.238.087.166.015.565.846.876.285.615.67

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Alkem Laboratories Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.